摘要
目的 分析医院静脉用药调配中心(PIVAS)不合理医嘱情况,为临床合理用药提供参考。方法 提取2023年度所有进入PIVAS需进行静脉调配的医嘱,医嘱总计782 670张,其中退回医嘱共1 887张。PIVAS审方药师对每一张处方进行人工前置审核。结果在退回医嘱中,不合理医嘱800张,占退回医嘱的42.40%。呼吸与危重症医学科、肿瘤内科的不合理医嘱占比最高(分别为33.38%、21.00%)。溶媒用量不合理、溶媒选择不合理、用法用量不合理、联合用药不合理为主要的不合理医嘱原因。结论 PIVAS审方药师应不断加强专业知识学习,提升审方技能和药学服务水平,以降低不合理医嘱率,保障患者用药安全。
Objective To analyze the situation of unreasonable medical orders in the hospital's intravenous admixture service(PIVAS)and provide references for rational drug use in clinical practice.Methods All medical orders that needed to be intravenously compounded and entered PIVAS in 2023 were extracted,totaling 782670 orders,among which 1887 orders were returned.The PIVAS prescription reviewers conducted manual pre-review on each prescription.Results Among the returned orders,800 were unreasonable,accounting for 42.40%of the returned orders.The departments with the highest incidence of unreasonable orders were the Department of Respiratory and Critical Care Medicine,and the Department of Oncology(33.38%and 21.00%respectively).The main reasons for the unreasonable orders were unreasonable solvent volume,unreasonable solvent selection,unreasonable dosage and administration,and unreasonable combination therapy.Conclusion PIVAS prescriptionreviewing pharmacists should continuously enhance their professional knowledge,improve their prescription review skills and pharmaceutical care levels,in order to reduce the rate of irrational prescriptions and ensure patient medication safety.
作者
李艳
屈伟
黄静
LI Yan;QU Wei;HUANG Jing(Department of Pharmacy,Jiangyin People’s Hospital,Jiangyin 214400,China)
出处
《中国处方药》
2025年第24期73-77,共5页
Journal of China Prescription Drug
基金
中国药学会全国医院信息网2021年科普研究项目(CMEI2021KPYJ00707)
江苏省药学会-天晴医院药学基金科研课题(Q202136)。
关键词
静脉用药调配中心
不合理医嘱
用法用量不合理
溶媒用量不合理
溶媒选择不合理
PIVAS
Unreasonable medical orders
Unreasonable dosage and administration
Unreasonable solvent volume
Unreasonable solvent selection
